Publications

Peer-Reviewed Journal Articles

  • Ha NB, Ha NB, Garcia RT, Trinh HN, Chaung KT, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. Dig Dig Sci 2011. In Press.
  • Edward S, Trinh HN, Nguyen TT, Do ST, Phuong T, Nguyen HA, Nguyen KK, Garcia RT, Nguyen MH. High rate of complete viral suppression with entecavir therapy in patients with chronic hepatitis B and partial response to adefovir. Aliment Pharmacol Ther 2011. In Press.
  • Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MH. Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naïve chronic hepatitis C genotype 6. Hepatology 2010; 52(5): 1573-80.
  • Nguyen NH, Vutien P, Garcia RT, Trinh H, Nguyen HA, Nguyen KK, Levitt B, Nguyen MH. Treatment Response and Tolerability to Pegylated Interferon (PEG Inf) and Ribavirin (RBV) in Treatment-Naïve Asian American Patients with Chronic Hepatitis C and Genotype 1, 2/3 and 6. J Viral Hepatitis 2010;17(10):691-7.
  • Nguyen NH, Vutien P, Trinh H, Garcia RT, Nguyen L, Nguyen HA, Nguyen KK, Nguyen MH. Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.  Hepatology International 2010;4(2): 523-9.
  • Nguyen MH, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Nguyen LH, Levitt B. Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B. Aliment Pharmacol Ther 2009;30:1150-1158.
  • Vutien PB, Nguyen NH, Trinh HN, Li J, Garcia RT, Garcia G, Nguyen KK, Nguyen HA, Levitt BS, Keeffe EB, Nguyen MH.  Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C.  Am J Gastroenterol 2010;105:1110-1115.
  • Wong CR, Garcia RT, Trinh HN, Lam KD, Ha NB, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH.  Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.  Dig Dis Sci 2009;54:2712-2721.
  • Ha N, Ha N, Garcia R, Trinh H, Nguyen H, Vu A, Nguyen K, Levitt B, Nguyen MH.  Renal dysfunction in patients with chronic hepatitis B treated with adefovir dipivoxil.  Hepatology 2009;50:727-734.
  • Nguyen MH, Garcia RT, Trinh H, Lam KD, Weiss G, Nguyen H, Nguyen K, Keeffe EB.  Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B Virus DNA, and normal alanine aminotransferase levels.  Am J Gastroenterol 2009;104:2206-2213.
  • Nguyen LH, Ha NB, Vutien P, Ha NB, Garcia RT, Trinh HN, Levitt BS, Nguyen HA, Nguyen KK, Keeffe EB, Nguyen MH.  Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B.  Hepatol Int 2009;3:461-467.
  • Nguyen G, Garcia R, Nguyen N, Trinh H, Keeffe EB, Nguyen MH.  Clinical outcomes of pregnant women with chronic hepatitis B who were previously asymptomatic.  Aliment Pharmacol Ther 2009;29:755-764.
  • Lam KD, Garcia RT, Trinh H, Nguyen LH, Phan JT, Nguyen K, Nguyen H, Ahmed A, Triadafilopoulos G, Nguyen MH.  Prevalence of colorectal neoplasms in Asian-Americans.  Dig Dis Sci 2009;54:160-167.
  • Lam KD, Phan JT, Garcia RT, Trinh H, Nguyen H, Nguyen K, Triadafilopoulos G, Vutien P, Nguyen MH.  Low proportion of Barrett’s esophagus in Asian-Americans.  Am J Gastroenterol 2008;103:1625-1630.
  • Tsang PSY, Garcia RT, Trinh H, Phan J, Ha N, Nguyen H, Nguyen K, Keeffe EB, Nguyen MH.  Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels.  Clin Gastroenterol Hepatol 2008;6:569-574.
  • Nguyen MH, Trinh H, Garcia RT, Nguyen G, Lam K, Keeffe EB.  Higher rate of sustained virologic response in treatment-naïve patients with chronic hepatitis C genotype 6 treated with 48 weeks compared to 24 weeks of peginterferon plus ribavirin.  Am J Gastroenterol 2008;103:1131-1135.


Back to Top

Abstracts

  • Chaung KT, Ha NB, Trinh HN, Ha NB, Garcia RT, Nguyen HA, Nguyen KK, Garcia G, Ahmed A, Keeffe EB, Nguyen MN. High rate of recurrent hepatitis B viremia following treatment-induced hepatitis B e antigen (HBeAg) seroconversion. Gastroenterology 2011; 140 (Suppl 1): S897. Oral presentation, Digestive Disease Week, Chicago Illinois, May 2011.  
  • Lin B, Ha NB, Liu A, Trinh HN, Nguyen HA, Nguyen KK, Garcia RT, Ahmed A, Garcia G, Keeffe EB, Nguyen MH. Incidence and predictors of hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B (CHB) patients treated with anti-HBV therapy in routine clinical practice. Gastroenterology 2011; 140 (Suppl 1): S913.
  • Liu A, Ha NB, Lin B, Yip B, Trinh HN, Nguyen HA, Nguyen KK, Ahmed A, Garcia G, Keeffe EB, Nguyen MH. Incidence of hepatitis B e antigen (HBeAg) seroconversion and suboptimal response in chronic hepatitis B (CHB) patients treated with entecavir 0.5 mg daily in routine clinical practice. Gastroenterology 2011; 140 (Suppl 1): S931-932.  
  • Nguyen V, Ha NB, Trinh HN, Nguyen HA, Nguyen KK, Garcia RT, Levitt BS, Nguyen MH. Long-term treatment response to entecavir and adefovir in treatment-naïve chronic hepatitis B e antigen-negative patients in a community setting. Gastroenterology 2011; 140 (Suppl 1): S933.
  • Nguyen MH, Trinh HN, Do ST, Tran PL, Nguyen TT, Nguyen KK, Nguyen HA, Garcia RT. Rapid complete viral suppression (CVS) with entecavir (ETV) in adefovir (ADV)-experienced patients: Interim report for a multicenter study. Gastroenterology 2011; S934.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen HA, Levitt BS, Keeffe EB, Cooper AD, Nguyen KK, Ayoub W, Daugherty T, Ahmed A. Hepatitis B virus (HBV) reverse transcriptase mutation prevalence was low in treatment-naïve patients with chronic hepatitis B (CHB) using INNO-LiPA HBV DR3 in a prospective multicenter study. Gastroenterology 2011; S973.
  • Ristau JT, Zhang S, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Nguyen MH. Proportion of patients who were previously ineligible for anti-HBV therapy who became eligible after 12 months of follow-up: application of U.S. Panel and AASLD Guidelines. Gastroenterology 2011; S896. Oral Presentation, DDW 2011.
  • Vutien P, Garcia RT, Trinh HN, Nguyen LH, Ha NB, Keeffe EB, Nguyen HA, Nguyen KK, Levitt BS, da Silveira EB, Nguyen MH. HBV precore C1858T mutation does not share similar clinical or virologic characteristics with other precore mutants. Gastroenterology 2011; 140 (Suppl 1): S921-922 
  • Zhang S, Ristau JT, Trinh HN, Garcia RT, Nguyen HA, Levitt BS, Nguyen MH. Treatment of chronic hepatitis B patients according to current guidelines: a community-based study. Gastroenterology 2011; S932.  
  • Do AL, Wong CR, Nguyen V, Garcia RT, Trinh HN, Kin KC, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Annual incidence for hepatocellular carcinoma (HCC) in non-cirrhotic patients with chronic hepatitis B (CHB) and cirrhotic patients of all etiologies. Gastroenterology 2011; S920.
  • Ha NB, Trinh HN, Ha NB, Nguyen HA, Nguyen KK, Nguyen MH. Response to Higher Dose of Entecavir (ETV) 1.0 mg Daily in Patients with Chronic Hepatitis B (CHB) and Partial Response to ETV 0.5 mg Daily. Hepatology 2010; 52(Suppl 1): 535A.
  • Wong CR, Trinh HN, Yip B, Nguyen HA, Garcia RT, Ahmed A, Keeffe EB, Nguyen MH. Rapid Complete Viral Suppression with Combination Therapy in 109 Treatment-Experienced Patients with Chronic Hepatitis B. Hepatology 2010; 52(Suppl 1): 544A.
  • Nguyen MH, Trinh HN, Do ST, Tran P, Nguyen T, Nguyen KK, Nguyen HA, Nguyen NH, Garcia RT. Complete viral suppression (CVS) by entecavir (ETV) in patients previously treated with adefovir (ADV): Interim report for a multicenter study. Hepatology 2010; 52(Suppl 1): 510A.
  • Yip B, Trinh HN, Nguyen HA, Chaung KT, Nguyen MH. Response to Alternative Therapies in Patients with Chronic Hepatitis B (CHB) and Entecavir (ETV) Partial Response (PR). Hepatology 2010; 52(Suppl 1): 535A
  • Ha NB, Ha NB, Ahmed A, Ayoub W, Daugherty T, Lutchman GA, Garcia G, Cooper AD, Keeffe EB, Nguyen MH. Risk Factors for Hepatocellular Carcinoma among Patients with Underlying Chronic Liver Disease: A Prospective Study. Hepatology 2010; 52(Suppl 1): 682A.
  • Ha NB, Trinh HN, Leduc TS, Bui C, Nguyen TT, Tran AT, Ha NB, Nguyen MH. Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California: A Cross-Sectional Study. Hepatology 2010; 52(Suppl 1): 696A.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Cooper AD, Levitt BS, Keeffe EB, Ayoub W, Daugherty T, da Silveira EB, Ahmed A. Low Prevalence of Hepatitis B Virus Reverse Transcriptase Mutations in Treatment-Naïve Patients with Chronic Hepatitis B Using INNO-LiPA HBV DR3 in a Multicenter Study. Hepatology 2010; 52(Suppl 1): 1001A.
  • Chaung KT, Trinh HN, Ha NB, Garcia RT, Nguyen HA, Nguyen MH. Virologic relapse following treatment induced hepatitis B e antigen seroconversion in chronic hepatitis B (CHB) patients. Am J Gastroenterol 2010; 105(Suppl 1): S100. Oral presentation, ACG 2010.
  • Ha NB, Ha NB, Ahmed A, Ayoub W, Daugherty T, Lutchman GA, Garcia G, Cooper AD, Gregory PB, Keeffe EB, Nguyen MN.  Ethnicity, alcohol consumption, and cigarette use as predictors for hepatocellular carcinoma: a prospective study.  Gastroenterology 2010;138:S-219.  Poster presentation with distinction, DDW 2010.
  • Ha NB, Trinh HN, Nguyen TT, Klapstein KD, Ha NB, Nguyen MN. Prevalence, risk factors, and disease knowledge of chronic hepatitis B (CHB) infection in Vietnamese Americans in California: A prospective study. Gastroenterology 2010;138:S-631.
  • Do AL, Wong CR, Nguyen V, Garcia RT, Trinh HN, Kin K, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MN. Hepatocellular carcinoma incidence in a cohort of 981 U.S. patients with chronic hepatitis B without cirrhosis and patients with cirrhosis of all etiologies. Gastroenterology 2010;138:S-776.  Oral presentation, DDW 2010.
  • Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MN. Randomized controlled trial of pegylated interferon-alpha 2a and ribavirin in patients with treatment-naïve chronic hepatitis C genotype 6. Gastroenterology 2010;138:S-783. Oral presentation, DDW 2010.
  • Nguyen MN, Trinh HN, Do ST, Tran PI, Nguyen TT, Nguyen KK, Nguyen HA, Nguyen NH, Garcia RT. Treatment efficacy of entecavir (ETV) therapy in patients previously treated with adefovir (ADV): Interim report for a multicenter study. Gastroenterology 2010;138:S-793.  Oral presentation, DDW 2010.
  • Wong CR, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Levitt BS, Ayoub W, Ahmed A, Keeffe EB, Nguyen MH.  High rate of complete viral suppression with combination therapy with tenofovir using entecavir or lamivudine/emtricitabine in patients with chronic hepatitis B and prior monotherapy failure.  Gastroenterology 2010;138:S-794.  Oral presentation, DDW 2010.
  • Verma K, Nguyen LH, Ahmed A, Daugherty T, Garcia G, Keeffe EB, Nguyen MH.  Both hepatitis C and B virus were major underlying etiologies for hepatocellular carcinoma (HCC) in Vietnamese American while the vast majority of HCC cases in Chinese Americans were associated with hepatitis B virus.  Gastroenterology 2010;138:S-813.
  • Nguyen MH, Garcia RT, Trinh HN, Levitt BS, da Silveria EB, Nguyen HA, Nguyen KK, Ahmed A, Keeffe EB.  Hepatitis B-e antigen positive (HBeAg+) chronic hepatitis B (CHB) patients with precore (PC) and basal core promoter (BCP) mutations.  Gastroenterology 2010;138:S-830. 
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Levitt BS, da Silveira EB, Ayoub W, Garcia G, Ahmed A, Keeffe EB.  Hepatitis B virus reverse transcriptase mutations were not detected in treatment-naïve patients with chronic hepatitis B using INNO LiPA HBV DR3: a prospective multicenter study.  Gastroenterology 2010;138:S-830.
  • Nguyen LH, Ko S, Wong SS, Tran P, Trinh HN, Garcia RT, Ahmed A, Lutchman GA, Keeffe EB, Nguyen MH.  Asian ethnicity is a significant predictor for viral dominance by HBV in HBV/HCV co-infected patients: a multicenter, matched case-control study.  Gastroenterology 2010;138:S-839.   Poster presentation with distinction, DDW 2010.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS, Chaung KT, Do A, Nguyen MH.  Long-Term Outcome of Treatment-Naïve Chronic Hepatitis B e Antigen-Negative Treated with Entecavir 0.5mg (ETV) or Adefovir 10mg (ADV) in a Real-Life Community Setting. Gastroenterology 2010;138:S-833.
  • Wong CR, Trinh HN, Garcia RT, Nguyen H, Nguyen K, Levitt BS, Nguyen MH.  Adherence to screening, incidence, predictors, and prognosis for hepatocellular carcinoma (HCC) in a cohort of U.S. patients with cirrhosis and chronic hepatitis B (CHB) without cirrhosis.  Hepatology 2009;50(Suppl):1085A.
  • Wong CR, Garcia RT, Trinh HN, Vutien P, Morgan ME, Nguyen H, Nguyen K, Levitt BS, Nguyen MH.  Response to tenofovir (TDF)-based combination chronic hepatitis B (CHB) with antiviral resistance (AvR) or partial response (PR) to prior monotherapy.  Hepatology 2009;50(Suppl):500A.
  • Nguyen MH, Trinh HN, Nguyen T, Do ST, Tran P, Nguyen KK, Nguyen HA, Nguyen NH, Garcia RT.  Complete viral suppression (CVS) and ALT normalization on entecavir (ETV) therapy in patients who were previously treated with adefovir (ADV): A multicenter study.  Hepatology 2009;50(Suppl):540A.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen KK, Nguyen HA, Wong CR, Levitt BS, da Silveira E.  No baseline mutations in the hepatitis B virus reverse transcriptase were detected in patients with treatment-naïve chronic hepatitis B using INNO LiPA HBV DR3: A prospective study.  Hepatology 2009;50(Suppl):493A.
  • Nguyen MH, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS.  Low prevalence of hepatitis B virus (HBV) DNA polymerase/reverse transcriptase (RT) mutations in a cohort of 472 treatment-naïve patients with chronic hepatitis B (CHB).  Hepatology 2009;50(Suppl):982A.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Nguyen KK, Nguyen HA, Levitt B, Vu AA, Nguyen MH.  Noncompliance antiviral resistance and virologic response (VR) in treatment-naïve HBeAg-negative patients with chronic hepatitis B (CHB) on long-term therapy with entecavir 0.5mg (ETV) or adefovir 10mg (ADV) in a real-life clinical setting.  Hepatology 2009;50(Suppl):513A.
  • Wong CR, Trinh HA, Garcia RT, Nguyen HN, Nguyen KK, Levitt BS, Nguyen MH.  Similar viral suppression rates with adefovir (ADV)-based combination therapy with either entecavir (ETV) or telbivudine (LdT)/lamivudine (LAM) in chronic hepatitis B patients with prior antiviral resistance or partial drug response at 6 and 12 Months.  Am J Gastroenterol 2009;104(Suppl):331.
  • Wan KS, Garcia RT, Trinh HN, Nguyen N, Wong CR, Nguyen H, Nguyen K, Nguyen MH.  How many patients with chronic hepatitis B (CHB) seen at a U.S. gastroenterology clinic would be eligible for antiviral therapy?  Am J Gastroenterol 2009;104(Suppl):417.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH.  Long-term treatment outcome of entecavir (ETV) monotherapy in treatment-naïve hepatitis B e antigen-positive chronic hepatitis B (CHB) patients in a real-life setting.  Am J Gastroenterol 2009;104(Suppl):348.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Nguyen MH.  Long-term outcome at year 5 in chronic hepatitis B (CHB) patients initially treated with adefovir dipivoxil (ADV) in a real-life clinical setting.  Gastroenterology 2009;136(Suppl):1801A.
  • Vutien P, Nguyen NH, Trinh HN, Li J, Garcia RT, Wong CR, Keeffe EB, Garcia G, Nguyen KK, Nguyen HA, Levitt BS, Nguyen MH. Response to peginterferon (PEG IFN) and ribavirin (RBV) in Asian Americans and non-Asian Americans with chronic hepatitis C (CHC) in a real-life community setting: A multicenter study.  Gastroenterology 2009;136(Suppl):1786A.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Vu AA, Nguyen KK, Nguyen HA, Levitt BS, Nguyen MH.  Long-term outcome of chronic hepatitis B patients initially treated with entecavir in a real-life clinical setting.  Gastroenterology 2009;136(Suppl):1807A.
  • Nguyen MH, Trinh HN, Do ST, Nguyen TT, Tran PL, Garcia RT, Nguyen NH, Nguyen HA, Nguyen KK.  Response to entecavir (ETV) in patients with chronic hepatitis B (CHB) and prior suboptimal response to adefovir (ADV): Interim report of a multicenter study.  Gastroenterology 2009;136(Suppl): 319A.  Oral presentation, DDW 2009.
  • Nguyen NH, Vutien P, Trinh HN, Garcia RT, Wan K, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH.  Treatment response and tolerability to pegylated Interferon (PEG IFN) and ribavirin (RBV) in treatment-naïve Asian-American patients with chronic hepatitis C and genotypes 1, 2/3 and 6.  Gastroenterology 2009;136(Suppl):11A.  Oral presentation, DDW 2009.
  • Ha NB, Ha NB, Trinh HN, Garcia RT, Vu AA, Nguyen KK, Nguyen HA, Levitt BS, Nguyen MH.  Changes in creatinine clearance (CrCl) in chronic hepatitis B (CHB) patients treated with adefovir dipivoxil (ADV).  Gastroenterology 2009;136(Suppl):1809A.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Wan K, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH.  Incidences of renal dysfunction in chronic hepatits B (CHB) patients treated with adefovir dipivoxil (ADV) 10 mg.  Gastroenterology 2009;136(Suppl):1813A.
  • Wong CR, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH.  Poor adherence to screening for hepatocellular carcinoma (HCC), especially in patients with chronic hepatitis B (CHB) without cirrhosis compared to patients with cirrhosis of all etiologies.  Gastroenterology 2009;136(Suppl):1777A.
  • Ha NB, Ha NB, Trinh HN, Garcia RT, De Luna W, Nguyen KK, Nguyen HA, Levitt BS, Nguyen MH.  Changes in creatinine clearance (CrCl) in chronic hepatitis B (CHB) patients with adefovir dipivoxil (ADV).  Hepatology 2008;48:902A.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen L, Nguyen HA, Nguyen KK, Levitt BS.  Treatment outcomes in patients with chronic hepatitis B (CHB) and partial response to adefovir (ADV) who were switched to entecavir (ETV).  Hepatology 2008;48:904A.
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS, Nguyen NH, Nguyen MH.  Long-term outcome of chronic hepatitis B (CHB) patients initially treated with adefovir dipivoxil (ADV) in a community practice.  Am J Gastroenterol 2008;103:80A.
  • Nguyen NH, Vutien P, Trinh HN, Garcia RT, Nguyen LH, Nguyen HA, Nguyen KK, Levitt BS, Ha NB, Nguyen MH.  Risk factors and novel genotypes in Southeast Asians infected with chronic hepatitis C.  Am J Gastroenterol 2008;103:53A.  Oral Presentation, ACG 2008.
  • Vutien P, Nguyen NH, Garcia RT, Trinh HN, Nguyen LH, Keeffe EB, Garcia G, Nguyen KK, Nguyen HA, Levitt BS, Nguyen MH.  Asian ethnicity is a significant predictor of sustained virologic response (SVR) to combination therapy with peginterferon (PEG IFN) and ribavirin (RBV) in chronic hepatitis C (CHC).  Hepatology 2008;48:1273A.
  • Nguyen LH, Ha NB, Vutien P, Ha NB, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS, Keeffe EB, Nguyen MH.  Vietnamese patients with chronic hepatitis B (CHB) exhibit different viral genotype distributions than Chinese patients.  Gastroenterology 2008;134(Suppl 1):309A.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen LH, Ha NB, Vutien P, Nguyen HA, Nguyen KK, Keeffe EB.  Almost half of the chronic hepatitis B (CHB) patients with positive HBeAg have confirmed precore and/or basal core promoter (PreC/BCP) mutations.  Gastroenterology 2008;134(Suppl 1):310A.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen LH, Vutien P, Ha NB, Nguyen HA, Nguyen KK, Keeffe EB, Ha NB.  Prevalence of HBV DNA polymerase (B-DNA pol) mutations in 345 patients with treatment-naïve chronic hepatitis B (CHB).  Gastroenterology 2008;134(Suppl 1):310A.
  • Nguyen MH, Trinh HN, Garcia RT, Phan J, Ha NB, Weiss G, Nguyen KK, Nguyen HA, Keeffe EB.  Age≥35 years is a predictor of significant histology in chronic hepatitis B (CHB) patients with normal ALT even with stricter cut-offs (≤30 for men and ≤19 for women).  Gastroenterology 2008;134(Suppl 1):310A.
  • Tsang PS, Garcia RT, Trinh HN, Phan J, Ha N, Nguyen H, Nguyen K, Keeffe EB, Nguyen MH.  Significant prevalence of histologic disease in chronic hepatitis B patients with mildly elevated serum alanine aminotrasferase levels.  Gastroenterology 2008;134(Suppl 1):312A.
  • Nguyen MH, Trinh H, Garcia R, Phan J, Nguyen G, Weiss G, Nguyen H, Nguyen K, Keeffe EB.  High prevalence of significant histologic disease in patients with chronic hepatitis B and normal ALT.  Hepatology 2007;46(Suppl):680A.
  • Nguyen MH, Trinh H, Garcia R, Phan J, Nguyen G, Nguyen H, Nguyen K, Keeffe EB.  Very high prevalence of chronic hepatitis B with mixed wild-type and precore/core promoter mutant virus, especially among older patients.  Hepatology 2007;46(Suppl):674A.
  • Lam KD, Nguyen MH, Trinh HN, Nguyen KK, Nguyen HA, Garcia RT.  Racial differences in rate of adenomas in small polyps in Asians compared to whites.  Am J Gastroenterol 2005;100(Suppl):1078.
  • Garcia RT, Lam KD, Trinh HN, Nguyen KK, Nguyen L, Nguyen HA, Nguyen MH.  Outcomes of screening colonoscopy in Asian-Americans compared to other ethnic groups.  Am J Gastroenterol 2005;100(Suppl):1077.
  • Nguyen L, Lam KD, Nguyen MH, Trinh HN, Nguyen KK, Nguyen HA, Garcia RT.  Outcomes of colonoscopic evaluation for rectal bleeding in Asian-Americans.  Am J Gastroenterol 2005;100(Suppl):411.
  • Nguyen MH, Trinh H, Garcia RT, Hoda K, Keeffe EB.  Response to combination therapy with interferon and ribavirin in patients with HCV genotype 6.  Hepatology 2005;42(Suppl):1201.
  • Nguyen MH, Trinh H, Garcia RT, Ahmed A, Keeffe EB.  Significant histologic disease in HBV-infected patients with normal to minimally elevated ALT levels at initial evaluation.  Hepatology 2005;42(Suppl);1201.
  • Nguyen MH, Trinh HN, Garcia RT, Vien P, Keeffe EB.  Hepatitis C is a major etiology for HCC in Vietnamese-Americans.  Am J Gastroenterol 2004;99(10 Suppl):260A.
  • Nguyen MH, Trinh HN, Garcia RT, Ning J, Keeffe EB.  High prevalence of novel genotypes in Vietnamese patients with hepatitis C.  Gastroenterology 2004;126:4(Suppl 2):2020A.
  • Nguyen MH, Trinh HN, Garcia RT, Ning J, Keeffe EB.  Evaluation and outcomes of combination therapy with interferon or pegylated interferon and ribavirin in a cohort of 67 Southeast Asian patients with hepatitis C genotypes 6, 7, 8, and 9.  Hepatology 2003;38:(Suppl 1):1014A.


Back to Top